122 results
Page 4 of 7
8-K
EX-99.1
84few98ckll ztnc
30 Jul 20
Other Events
12:00am
8-K
EX-99.1
rol ek2f6pj7wdl
11 May 20
Recro Reports First Quarter 2020 Financial Results and Provides Update onCOVID-19 Response and Impact
7:31am
DEFA14A
v55x urho7icfq9sn
1 May 20
Additional proxy soliciting materials
4:57pm
8-K
EX-99.1
jfyuz0kqgrg344yu
4 Mar 20
Recro Reports Financial Results for the Year Ended 2019
7:00am
8-K
EX-2.1
67lw1
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.2
jllrl kq3
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
bl5izfe
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
l25pa6 xbd
5 Nov 19
Recro Pharma’s Board of Directors Approves Separation of Acute
7:07am
8-K
EX-99.1
gx5iaocy
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
uf10w
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
dmcr43w
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
dd80s8ot bwtq2e
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
6wpr5q
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
37wpfcgut5yett5kaj
22 Mar 19
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
4:17pm